Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$998,174
-$27,275,409 QoQ
Shares Held
28,205
-97.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#239
of 497 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Derivatives in ROIV
reported options exposure · as of Jun 30, 2026CallValue
$257,830,306
CallShares
7,285,400
PutValue
$4,126,474
PutShares
116,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. ROIV ranks #85 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in ROIV
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,126,474 | 116,600 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $257,830,306 | 7,285,400 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $998,174 | 28,205 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $988,890 | 35,700 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $3,717,340 | 134,200 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $28,273,583 | 1,020,707 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $5,939,290 | 273,700 | Put | Defined | 2026-02-12 | |
| 2025-12-31 | $28,461,393 | 1,311,585 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $11,518,360 | 530,800 | Call | Defined | 2026-02-12 | |
| 2025-09-30 | $3,932,287 | 259,900 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $41,543,528 | 2,745,772 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $5,814,459 | 384,300 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $246,813 | 21,900 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $2,095,093 | 185,900 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $13,769,121 | 1,221,750 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,376,647 | 532,869 | Shares | Defined | 2025-05-19 | |
| 2025-03-31 | $263,349 | 26,100 | Put | Defined | 2025-05-19 | |
| 2025-03-31 | $169,512 | 16,800 | Call | Defined | 2025-05-19 | |
| 2024-12-31 | $505,141 | 42,700 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $361,501 | 30,558 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $450,723 | 38,100 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $2,451,096 | 212,400 | Call | Defined | 2024-11-15 | |
| 2024-09-30 | $168,437 | 14,596 | Shares | Defined | 2024-11-15 | |
| 2024-09-30 | $3,021,172 | 261,800 | Put | Defined | 2024-11-15 | |
| 2024-06-30 | $26,507,265 | 2,507,783 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $7,391,459 | 701,277 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $3,535,742 | 314,848 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $21,132,285 | 1,809,271 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $2,884,432 | 286,154 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,802,631 | 244,259 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $707,737 | 88,578 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $48,035 | 14,918 | Shares | Defined | 2022-11-15 | |
| 2022-03-31 | $246,491 | 49,897 | Shares | Defined | 2022-05-17 | |
| No filing history on record for this holder in this stock. | ||||||